Cargando…
Safety and efficacy of two-drug combination in elderly patients with locally advanced non-small cell lung cancer and validation of the Charlson Index as a predictor of survival
BACKGROUND: The best platinum-based chemotherapy regimen remains to be determined in elderly patients treated with definitive chemoradiotherapy for advanced non-small cell lung cancer (NSCLC). Predictive indexes for toxicity and survival are also needed to give the safest and most effective treatmen...
Autores principales: | Lach, Maciej, Otto, Josiane, Bondiau, Pierre-Yves, Boulahssass, Rabia, Schiappa, Renaud, Jazmati, Danny, von Krüchten, Ricarda, Martin, Nicolas, Doyen, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407508/ https://www.ncbi.nlm.nih.gov/pubmed/37559621 http://dx.doi.org/10.21037/jtd-23-108 |
Ejemplares similares
-
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
por: Benzaquen, Jonathan, et al.
Publicado: (2023) -
Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018) -
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022) -
The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
por: Zhou, Shi, et al.
Publicado: (2022) -
Charlson Comorbidity Index as a Predictor of Difficult Cholecystectomy in Patients With Acute Cholecystitis
por: Alburakan, Ahmed A, et al.
Publicado: (2022)